tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Novak, 22 are a BUY (95.65%), 1 are a HOLD (4.35%).
Analyst David Novak, carries an average stock price target met ratio of 50.93% that have a potential upside of 47.6% achieved within 245 days. Previously, David Novak worked at RAYMOND JAMES.
David Novak’s has documented 43 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ZYME, Zymeworks at 09-Dec-2021.
Analyst best performing recommendations are on IMV (IMV).
The best stock recommendation documented was for IMV (IMV) at 7/16/2021. The price target of $20 was fulfilled within 10 days with a profit of $6.2 (44.93%) receiving and performance score of 44.93.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Jul-2025
$27
$15.16 (128.04%)
$27
1 months 6 days ago
(14-Sep-2026)
0/3 (0%)
$7.32 (37.20%)
Buy Since 24-Jun-2025
$30
$18.16 (153.38%)
$30
3 months 27 days ago
(23-Jun-2026)
0/6 (0%)
$12.5 (71.43%)
Buy Since 11-Aug-2025
$22
4 months 19 days ago
(01-Jun-2026)
2/2 (100%)
$10.8 (96.43%)
152
Buy Since 21-Jan-2026
$35
$20.68 (144.41%)
8 months 29 days ago
(21-Jan-2026)
0/1 (0%)
$21.28 (155.10%)
Buy Since 25-Aug-2025
$26
$11.68 (81.56%)
1 years 1 months 25 days ago
(25-Aug-2025)
1/1 (100%)
$11.3 (76.87%)
240
